The thyroid gland
Medullary thyroid cancer is the central feature of MEN 2. It begins in the C cells of the thyroid and is the main reason the condition is monitored and treated so carefully.
An inherited cause of medullary thyroid cancer
MEN 2 syndrome & thyroid cancer (the RET gene)
Medically reviewed by Dr. Owais Mohammed, Medical Oncologist, MBBS · MD · Last reviewed June 2026
Multiple Endocrine Neoplasia type 2 — MEN 2 — is an inherited condition caused by a change in the RET gene. It runs in families and greatly raises the risk of medullary thyroid cancer. Understanding it helps you protect not only yourself, but the people you love.
- It is inherited — a faulty RET gene passed down through families, present from birth
- It drives medullary thyroid cancer — almost all carriers develop it without preventive care
- Families can be tested — one RET result can protect parents, siblings and children
- Acting early changes the outlook — preventive surgery can stop cancer before it starts
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Is MEN 2 Syndrome?
MEN 2 is short for Multiple Endocrine Neoplasia type 2. It is an inherited condition — meaning it is passed down through families — caused by a change in a single gene called RET. Because the change is present from birth in every cell of the body, it can be carried for many years before it causes any problem.
The reason MEN 2 matters so much is its link to the thyroid. Nearly everyone with MEN 2 will develop medullary thyroid cancer at some point if nothing is done, often at a younger age than usual. MEN 2 can also affect other hormone-making glands, which is why it is described as a syndrome rather than a single disease.
The good news is that MEN 2 is one of the most preventable forms of cancer risk we know of. A simple genetic test can show who in a family carries the RET change — and those who do can be watched closely, or offered preventive surgery, long before cancer ever develops.
Did you know?
MEN 2 is inherited in an autosomal dominant way — which means each child of a person who carries the RET change has about a 1 in 2 chance of carrying it too. That is why testing one family member can open the door to protecting many. (Source: American Thyroid Association — Medullary Thyroid Carcinoma guidelines.)
What MEN 2 can affect
The Glands MEN 2 Can Involve
MEN 2 is called a syndrome because it can affect more than one hormone-making gland. Knowing what to watch for is how problems are found early.
The adrenal glands
A tumour called a phaeochromocytoma can grow on an adrenal gland and cause episodes of high blood pressure, palpitations or sweating. It is checked for before any thyroid surgery.
The parathyroid glands
In the MEN2A form, the parathyroid glands can become overactive and raise blood calcium. This is usually milder and is picked up through routine blood checks.
MEN2A and MEN2B — and Who Carries the Gene
There are two main forms of MEN 2, and both come from changes in the RET gene. MEN2A is the more common form and is linked to medullary thyroid cancer, adrenal tumours and overactive parathyroid glands. MEN2B is rarer; it tends to cause thyroid cancer at a very young age and brings other physical features, but not parathyroid problems.
MEN 2 is familial — it runs in families. If a parent carries the RET change, each of their children has about a one-in-two chance of inheriting it. This is why a diagnosis in one person is never only about that person; it is a signal to look after the whole family. A family history of medullary thyroid cancer, an adrenal tumour, or a known RET change is the clearest reason to be tested.
Not sure whether thyroid cancer runs in your family? Our guide to hereditary thyroid cancer explains who should consider testing — or speak to a CION specialist directly.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
MEN 2 Is Best Managed by a Team
Because MEN 2 touches the thyroid, the adrenal and parathyroid glands — and the whole family — it needs more than one opinion. Our tumour board reviews every case together. No rushed decisions, no unnecessary tests.
How RET Testing and MEN 2 Care Works
When MEN 2 is suspected — usually because of a medullary thyroid cancer diagnosis or a family history — care follows a clear, careful sequence. The aim is always to act before cancer can spread, not after.
Genetic counselling first
Before any test, a counsellor explains what RET testing can show, what the results may mean for you and your family, and how to share them. Nothing is rushed — the decision to test is always yours.
RET genetic test
A simple blood sample is checked for changes in the RET gene. The exact change found helps doctors judge how high the cancer risk is and how early the thyroid may need attention.
Calcitonin and gland checks
A calcitonin blood test shows whether the thyroid C cells are already overactive. Doctors also check the adrenal glands for a phaeochromocytoma and, in MEN2A, the parathyroid glands — before any surgery is planned.
A plan tailored to you
With the full picture, the tumour board agrees a plan — which may mean close monitoring, preventive thyroid surgery, or treatment if cancer is already present. The timing is set by your RET result and calcitonin level, case by case.
Testing the family
If an inherited RET change is confirmed, close relatives are offered the same test. Those who carry it can be protected; those who do not are reassured and need no extra monitoring.
Did you know?
When a phaeochromocytoma is present, it must be found and treated before any thyroid surgery — operating on the thyroid first could be dangerous. This is exactly why MEN 2 is managed as a whole-body condition by a coordinated team, not one gland at a time. (Source: NCCN Clinical Practice Guidelines in Oncology — Neuroendocrine and Adrenal Tumors.)
Preventive Surgery and Lifelong Monitoring
Because the thyroid cancer risk in MEN 2 is so high, the approach is to stay one step ahead of it rather than wait.
Preventive (prophylactic) thyroidectomy. For people who carry a RET change, doctors often recommend removing the thyroid before cancer develops or spreads. The right timing depends on the exact RET change and on calcitonin levels, and can range from early childhood to later — it is decided carefully, case by case, never rushed.
Watching the other glands. People with MEN 2 also have regular checks of the adrenal and, in MEN2A, the parathyroid glands. Finding a phaeochromocytoma or a calcium problem early means it can be treated safely and on time.
Following calcitonin over time. After thyroid surgery, calcitonin and a second marker called CEA are tracked. A low or undetectable level is reassuring; a rising level can flag a return of disease early, often before any symptom appears. You can read more about the wider pathway on our medullary thyroid cancer page.
Every plan at CION is decided by a tumour board — surgical, medical and radiation oncologists together — not a single doctor's opinion. We walk this journey with you and your family.
Why Families With MEN 2 Choose CION Cancer Clinics
MEN 2 is uncommon and affects whole families, so it helps to be cared for by a team that treats it regularly. Here is what you can expect at CION.
- Free 45-minute consultation — unhurried time with a specialist to explain MEN 2 and the plan ahead
- Tumour board for every patient — your case is reviewed by surgical, medical and radiation oncologists together
- RET genetic testing and counselling — for you and, where needed, for your whole family
- Whole-body, coordinated care — thyroid, adrenal and parathyroid glands managed together, in the right order
- No unnecessary tests, ever — investigations are arranged only when they genuinely change your care
- Transparent costs and clear next steps — decisions for healing, not billing
A MEN 2 diagnosis raises questions about you and the people you love. Book a free consultation and we will walk this journey with you.
From our patients
Stories From People We Have Walked Beside
Real stories from patients and families who trusted our team through testing, surgery, and the journey beyond.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
MEN 2 Syndrome & the RET Gene — Your Questions Answered
What is MEN 2 syndrome?
MEN 2 stands for Multiple Endocrine Neoplasia type 2. It is an inherited condition caused by a change in a gene called RET that is passed down through families. People with MEN 2 have a much higher chance of developing medullary thyroid cancer, and they can also develop tumours in other hormone-making glands — most often an adrenal tumour called a phaeochromocytoma, and sometimes an overactive parathyroid gland. There are two main forms, MEN2A and MEN2B, which differ in the other features they bring. Because the condition runs in families, finding it in one person allows relatives to be tested and protected.
How is MEN 2 linked to thyroid cancer?
Almost everyone with MEN 2 will develop medullary thyroid cancer (MTC) at some point if the thyroid is not removed, which is why the two are so closely linked. MTC starts in the C cells of the thyroid, and the faulty RET gene that causes MEN 2 makes those cells grow uncontrollably. In MEN 2 families the cancer often appears at a younger age than in people without an inherited change. This strong link is the reason that anyone diagnosed with medullary thyroid cancer is offered RET testing, and why members of a known MEN 2 family are monitored or offered preventive surgery.
What is the RET gene?
The RET gene carries the instructions for a protein that helps cells grow and send signals in a normal, controlled way. When the RET gene carries a fault, the C cells of the thyroid can grow out of control and form medullary thyroid cancer. In MEN 2, this RET change is inherited — it is present in every cell of the body and can be passed to children. Knowing a person's RET status matters for two reasons: it tells their family who else should be tested, and in advanced disease it can guide which targeted medicines may help.
What is the difference between MEN2A and MEN2B?
Both MEN2A and MEN2B are caused by RET changes and both carry a high risk of medullary thyroid cancer, but the other features differ. MEN2A is the more common form and is linked to adrenal tumours (phaeochromocytoma) and an overactive parathyroid gland. MEN2B is rarer and tends to cause medullary thyroid cancer at a very young age, along with other physical features and adrenal tumours, but not parathyroid problems. The exact RET change a family carries helps doctors judge how early the thyroid should be removed and what else needs watching. Your specialist will explain which form applies to you.
Should my family be tested for the RET gene?
If you have MEN 2 or hereditary medullary thyroid cancer, then yes — your close blood relatives should usually be offered RET genetic testing. Identifying who carries the same RET change is one of the most valuable things to come from a diagnosis. Relatives who carry the gene can be watched closely with calcitonin tests, and in many cases offered preventive removal of the thyroid before cancer develops. Relatives who do not carry the change are reassured and need no extra monitoring. At CION, genetic counselling is part of how we care for every family touched by MEN 2.
What other health problems can MEN 2 cause?
Beyond medullary thyroid cancer, MEN 2 can affect other hormone-making glands. The most important is the adrenal gland, where a tumour called a phaeochromocytoma can develop and cause episodes of high blood pressure, palpitations, headaches and sweating. In MEN2A, the parathyroid glands can become overactive and raise blood calcium. Because these problems can be silent at first, people with MEN 2 are offered regular checks — including blood and urine tests for the adrenal glands — so any problem is found and treated early. This is why MEN 2 is managed by a team, not a single doctor.
What is preventive (prophylactic) thyroid surgery in MEN 2?
Because the risk of medullary thyroid cancer in MEN 2 is so high, doctors often recommend removing the thyroid before cancer has a chance to develop or spread — this is called prophylactic, or preventive, thyroidectomy. The timing depends on which RET change a person carries and on their calcitonin levels, and it can range from early childhood to later, decided case by case. It can feel like a big step, but for many families it removes the lifelong worry of cancer and offers the best chance of a normal life. This decision is always made carefully, with full counselling, never rushed.
At what age does MEN 2-related thyroid cancer appear?
Medullary thyroid cancer linked to MEN 2 tends to appear earlier than the sporadic, non-inherited form. The exact age depends on the specific RET change a family carries — some changes are linked to cancer in early childhood, while others act later. This is precisely why timing of monitoring and preventive surgery is tailored to each family. There is no single age that fits everyone, so the right plan is set by a specialist who knows the family's RET result. The aim is always to act before cancer can spread, not after.
How is medullary thyroid cancer in MEN 2 monitored?
Monitoring centres on a blood test called calcitonin, the hormone made by the thyroid C cells where this cancer starts. A neck ultrasound is used alongside it to look at the thyroid and nearby lymph nodes. After any surgery, calcitonin and a second marker called CEA are followed over time: a low or undetectable level is reassuring, while a rising level can flag a return of disease early. People with MEN 2 also have regular checks of the adrenal and parathyroid glands. This watchful approach lets problems be caught and treated before they become serious.
Can MEN 2 be cured?
MEN 2 is an inherited condition, so the gene change itself stays with a person for life and cannot be removed. What can be done — and done very effectively — is to manage the risks it brings. Removing the thyroid prevents or treats medullary thyroid cancer, adrenal tumours can be removed, and parathyroid problems can be corrected. With careful monitoring and a clear plan, many people with MEN 2 live full lives. The goal is not to cure the gene but to stay one step ahead of the conditions it can cause, which is why ongoing specialist care matters.
Why choose CION for MEN 2 and hereditary thyroid cancer care?
MEN 2 is uncommon and affects whole families, so it helps to be cared for by a team that treats it regularly. At CION, every case is reviewed by a tumour board — surgical, medical and radiation oncologists together — rather than relying on one doctor's view. We offer RET genetic testing and counselling for you and your relatives, careful thyroid and neck surgery planned to be done well the first time, and clear monitoring afterwards. Your first 45-minute consultation is free, costs are explained upfront, and we order no unnecessary tests. We walk this journey with you and your family.
Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your situation. This page is periodically reviewed and updated by CION's medical team in line with current clinical guidelines.
Explore more
Thyroid Cancer Topics
Browse our complete guide to thyroid cancer — types, symptoms, causes, tests, stages and treatment. Tap any topic to read more.
Treatment & Specialist Care
Types of Thyroid Cancer
Symptoms & Warning Signs
Causes & Risk Factors
Tests & Diagnosis
Stages, Survival & Prognosis
Treatment & Procedures
Thyroidectomy Surgery
Thyroid Lobectomy
Neck Dissection
Radioactive Iodine (RAI)
Low-Iodine Diet for RAI
Targeted Therapy
External Beam Radiation
Does It Need Chemotherapy?
Treatment Without Surgery
Active Surveillance
Hormone Replacement & TSH
RAI-Refractory Disease
Anaplastic Cancer Treatment
Treatment Side Effects